Small Cell Lung Cancer

Overview

Journal Br J Cancer

Specialty Oncology

Date 1989 Apr 1

PMID 2540787

Citations 4

Authors

R C Leonard

Affiliations

Soon will be listed here.

Citing Articles

Indium-111 pentetreotide in the diagnostic work-up of patients with bronchogenic carcinoma.

Kirsch C, von Pawel J, Grau I, Tatsch K Eur J Nucl Med. 1994; 21(12):1318-25.

PMID: 7875170 DOI: 10.1007/BF02426696.

Is the progress in cancer treatment results adequate or are we confronted with a more or less worldwide stagnation.

Karrer K J Cancer Res Clin Oncol. 1990; 116(5):425-30.

PMID: 2172256 DOI: 10.1007/BF01612987.

A Medical Research Council phase II trial of alternating chemotherapy and radiotherapy in small-cell lung cancer. The Medical Research Council Lung Cancer Working Party.

Bleehen N, Girling D, Gregor A, Leonard R, Machin D, MCKENZIE C Br J Cancer. 1991; 64(4):775-9.

PMID: 1654988 PMC: 1977679. DOI: 10.1038/bjc.1991.397.

Treatment of relapse of small cell lung cancer in selected patients with the initial combination chemotherapy carboplatin, etoposide, and epirubicin.

Collard P, Weynants P, Francis C, Rodenstein D Thorax. 1992; 47(5):369-71.

PMID: 1319088 PMC: 463753. DOI: 10.1136/thx.47.5.369.

References

Zigmond A, SNAITH R . The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6):361-70. DOI: 10.1111/j.1600-0447.1983.tb09716.x. View

Klastersky J, Nicaise C, Longeval E, Stryckmans P . Cisplatin, adriamycin, and etoposide (CAV) for remission induction of small-cell bronchogenic carcinoma. Cancer. 1982; 50(4):652-8. DOI: 10.1002/1097-0142(19820815)50:4<652::aid-cncr2820500406>3.0.co;2-8. View

Holoye P, Kalbfleisch J . The influence of myelosuppression on the response to chemotherapy in small cell bronchogenic carcinoma. Cancer. 1984; 54(3):411-5. DOI: 10.1002/1097-0142(19840801)54:3<411::aid-cncr2820540307>3.0.co;2-5. View

Sculier J, Klastersky J, Stryckmans P . Late intensification in small-cell lung cancer: a phase I study of high doses of cyclophosphamide and etoposide with autologous bone marrow transplantation. J Clin Oncol. 1985; 3(2):184-91. DOI: 10.1200/JCO.1985.3.2.184. View

Smith I, Evans B, Harland S, Robinson B, Yarnold J, Glees J . High-dose cyclophosphamide with autologous bone marrow rescue after conventional chemotherapy in the treatment of small cell lung carcinoma. Cancer Chemother Pharmacol. 1985; 14(2):120-4. DOI: 10.1007/BF00434349. View

Stahel R, MABRY M, SKARIN A, Speak J, Bernal S . Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody. J Clin Oncol. 1985; 3(4):455-61. DOI: 10.1200/JCO.1985.3.4.455. View

Cunningham D, Banham S, Hutcheon A, Dorward A, Ahmedzai S, Tansey P . High-dose cyclophosphamide and VP 16 as late dosage intensification therapy for small cell carcinoma of lung. Cancer Chemother Pharmacol. 1985; 15(3):303-6. DOI: 10.1007/BF00263906. View

Fargion S, Carney D, Mulshine J, Rosen S, Bunn P, Jewett P . Heterogeneity of cell surface antigen expression of human small cell lung cancer detected by monoclonal antibodies. Cancer Res. 1986; 46(5):2633-8. View

Livingston R . Small-cell lung cancer--whither late intensification?. J Clin Oncol. 1986; 4(10):1437-8. DOI: 10.1200/JCO.1986.4.10.1437. View

10.

Ihde D, Deisseroth A, Lichter A, Bunn P, Carney D, Cohen M . Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer. J Clin Oncol. 1986; 4(10):1443-54. DOI: 10.1200/JCO.1986.4.10.1443. View

11.

Smyth J, Fowlie S, Gregor A, Crompton G, Busuttil A, Leonard R . The impact of chemotherapy on small cell carcinoma of the bronchus. Q J Med. 1986; 61(234):969-76. View

12.

Humblet Y, Symann M, Bosly A, Delaunois L, Francis C, Machiels J . Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study. J Clin Oncol. 1987; 5(12):1864-73. DOI: 10.1200/JCO.1987.5.12.1864. View

13.

Allan S, Hay F, McIntyre M, Leonard R . Prognosis in small cell carcinoma of the lung--relationship to human milk fat globule 2 (HMFG2) antigen and other small cell associated antigens. Br J Cancer. 1987; 56(4):485-8. PMC: 2001819. DOI: 10.1038/bjc.1987.229. View

14.

Slevin M, Plant H, Lynch D, Drinkwater J, Gregory W . Who should measure quality of life, the doctor or the patient?. Br J Cancer. 1988; 57(1):109-12. PMC: 2246701. DOI: 10.1038/bjc.1988.20. View

15.

Seifter E, Ihde D . Therapy of small cell lung cancer: a perspective on two decades of clinical research. Semin Oncol. 1988; 15(3):278-99. View

16.

Green R, Humphrey E, CLOSE H, PATNO M . Alkylating agents in bronchogenic carcinoma. Am J Med. 1969; 46(4):516-25. DOI: 10.1016/0002-9343(69)90071-0. View

17.

SNAITH R, Constantopoulos A, Jardine M, McGuffin P . A clinical scale for the self-assessment of irritability. Br J Psychiatry. 1978; 132:164-71. DOI: 10.1192/bjp.132.2.164. View

18.

Einhorn L, BOND W, Hornback N, Joe B . Long-term results in combined-modality treatment of small cell carcinoma of the lung. Semin Oncol. 1978; 5(3):309-13. View

19.

Stewart P, Buckner C, Thomas E, Bagley C, Bensinger W, Clift R . Intensive chemoradiotherapy with autologous marrow transplantation for small cell carcinoma of the lung. Cancer Treat Rep. 1983; 67(12):1055-9. View